Ergoteles’s Ambev ABEV Stock Holding History

Ergoteles’s Portfolio ABEV Stock Details ABEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,930,073	Closed	-$5.29M	–	1456
2021 Q1	$5.29M	Buy	+1,930,073	New	+$5.45M	0.16%	159

Other funds holding ABEV

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

SIM

Sprucegrove Investment Management Toronto, Ontario, Canada $639M AUM 23.31% 1-Year Est. Return

Ruffer LLP London, United Kingdom $2.83B AUM 30.34% 1-Year Est. Return

WGI

Westwood Global Investments Boston, Massachusetts $2.85B AUM 55.09% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AKO Capital London, United Kingdom $4.29B AUM 4.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ergoteles's ABEV Position: Q2 2021 in Review

Ergoteles sold out of Ambev (ABEV) in Q2 2021, closing a stake of 1,930,073 shares — an estimated $5.29M sold.

Ergoteles first reported a position in ABEV in Q1 2021 and held it in 1 quarter. The position peaked at $5.29M in Q1 2021. 280 funds tracked by Wall St. Rank hold ABEV as of Q2 2021.

Ergoteles reported no remaining Ambev position as of Q2 2021 after selling out during the quarter.
Ergoteles sold 1,930,073 Ambev shares in Q2 2021, an estimated $5.29M.
Ergoteles first reported a position in Ambev in Q1 2021 and held it in 1 quarter.
Ergoteles's Ambev position peaked at $5.29M in Q1 2021.
280 funds tracked by Wall St. Rank held Ambev as of Q2 2021.

Based on Ergoteles's 13F filing for Q2 2021, filed 12 Aug 2021.